Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mersana Therapeutics, Inc. - Common Stock (NQ:MRSN)

0.2960 +0.0060 (+2.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,571,261
Open 0.3200
Bid (Size) 0.2965 (2)
Ask (Size) 0.3011 (1)
Prev. Close 0.2900
Today's Range 0.2800 - 0.3170
52wk Range 0.2589 - 2.830
Shares Outstanding 71,761,525
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Top movers in Thursday's after hours session
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill

Performance

YTD
-78.9%
-78.9%
1 Month
-13.9%
-13.9%
3 Month
-14.0%
-14.0%
6 Month
-79.2%
-79.2%
1 Year
-85.0%
-85.0%

More News

Read More
Earnings Scheduled For March 3, 2025
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Earnings Preview For Mersana Therapeutics
Via Benzinga
Earnings Scheduled For May 15, 2025
Via Benzinga
An Overview of Mersana Therapeutics's Earnings
Via Benzinga
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts
Via Benzinga
Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
What To Know About Citigroup's Upgrade of Mersana Therapeutics
Via Benzinga
MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
Via InvestorPlace
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
Via PressReach
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is Mersana Therapeutics, Inc. - Common Stock publicly traded?
Yes, Mersana Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Mersana Therapeutics, Inc. - Common Stock trade on?
Mersana Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mersana Therapeutics, Inc. - Common Stock?
The ticker symbol for Mersana Therapeutics, Inc. - Common Stock is MRSN on the Nasdaq Stock Market
What is the current price of Mersana Therapeutics, Inc. - Common Stock?
The current price of Mersana Therapeutics, Inc. - Common Stock is 0.2960
When was Mersana Therapeutics, Inc. - Common Stock last traded?
The last trade of Mersana Therapeutics, Inc. - Common Stock was at 06/30/25 04:00 PM ET
What is the market capitalization of Mersana Therapeutics, Inc. - Common Stock?
The market capitalization of Mersana Therapeutics, Inc. - Common Stock is 21.24M
How many shares of Mersana Therapeutics, Inc. - Common Stock are outstanding?
Mersana Therapeutics, Inc. - Common Stock has 21M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.